Connection
Edwin deZoeten to Melanoma, Experimental
This is a "connection" page, showing publications Edwin deZoeten has written about Melanoma, Experimental.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.432 |
|
|
|
-
de Zoeten EF, Markovic D, Cohen EP. An optimum anti-melanoma response in mice immunized with fibroblasts transfected with DNA from mouse melanoma cells requires the expression of both syngeneic and allogeneic MHC-determinants. Gene Ther. 2002 Sep; 9(17):1163-72.
Score: 0.186
-
de Zoeten EF, Carr-Brendel V, Cohen EP. Resistance to melanoma in mice immunized with semiallogeneic fibroblasts transfected with DNA from mouse melanoma cells. J Immunol. 1998 Mar 15; 160(6):2915-22.
Score: 0.137
-
de Zoeten EF, Li D, Cohen EP. Tumor immunity in mice immunized with fibroblasts transfected with tumor DNA. Adv Exp Med Biol. 2001; 495:393-401.
Score: 0.041
-
Sun T, Carr-Brendel V, De Zoeten EF, Cohen EP. Immunization with interleukin-2-secreting allogeneic cells transfected with DNA from mouse melanoma cells induces immune responses that prolong the lives of mice with melanoma. Cancer Gene Ther. 1998 Mar-Apr; 5(2):110-8.
Score: 0.034
-
Xu W, de Zoeten E, Carr-Brendel V, Cohen EP. Co-expression of immunogenic determinants by the same cellular immunogen is required for the optimum immunotherapeutic benefit in mice with melanoma. Cancer Immunol Immunother. 1998 Jan; 45(5):217-24.
Score: 0.034